Table 2 Detectability of antibodies against SARS-CoV-2 one year after infection
| Adults (age > 17 years) | Children/adolescents | |
|---|---|---|
| HED subjects (n = 6) | ||
| Subjects with antibodies against the SARS-CoV-2 nucleocapsid | 3/4 | 1/2 |
| Subjects with antibodies against the SARS-CoV-2 spike S1 protein | 3/4 | 1/2 |
| Average concentration (BAU/ml) | 88.17 | 57.60 |
| Standard deviation | 32.43 | n. a |
| Control subjects (n = 20) | ||
| Subjects with antibodies against the SARS-CoV-2 nucleocapsid | 9/13 | 6/7 |
| Subjects with antibodies against the SARS-CoV-2 spike S1 protein | 7/13 | 6/7 |
| Average concentration (BAU/ml) | 170.31 | 160.45 |
| Standard deviation | 118.44 | 137.41 |